Form 4: Therapeutic Solutions International CEO Acquires 20 Million Shares at Discounted Price
SEC Form 4 Filing
Timothy G. Dixon, President & CEO of Therapeutic Solutions International, acquires 20,000,000 shares of common stock at $0.0006 per share.
Summary
- Timothy G. Dixon, the President & CEO of Therapeutic Solutions International, acquired 20,000,000 shares of common stock on July 11, 2024.
- The purchase price was $0.0006 per share.
- Following the transaction, Mr. Dixon beneficially owns 507,683,578 shares of the company's common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. While insider buying can be positive, the very low price per share raises concerns.
Positives
- The CEO's purchase could be interpreted as a sign of confidence in the company's future prospects.
Risks
- The acquisition price of $0.0006 per share is significantly low, which could raise questions about the valuation of the company's stock.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders. This filing indicates the CEO's recent stock purchase.
Stakeholder Impact
- Shareholders may view the CEO's purchase as a positive signal, but the low price per share could also cause concern.
Key Dates
| Date | Description |
|---|---|
| 07/11/2024 | Date of the stock transaction |
| 07/12/2024 | Date of signature on the Form 4 |
Keywords
Therapeutic Solutions International, TSOI, Timothy G. Dixon, stock acquisition, beneficial ownership, Form 4, SEC
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.